The following is a reconciliation of the weighted average shares outstanding used to compute basic and diluted net loss per common share:


	Three Months Ended March 31,
	2026		2025
Basic weighted average common shares outstanding		35,665,590		35,273,783
Effect of dilutive securities - equity compensation awards		—		—
Diluted weighted average common shares outstanding		35,665,590		35,273,783

Equity compensation awards for which total employee proceeds from exercise exceed the average fair value of the same equity incentive instrument over the period have an anti-dilutive effect on earnings per share during periods with net income, and accordingly, are excluded from diluted weighted average common shares outstanding. Due to the net loss incurred during the three months ended March 31, 2026 and 2025, the assumed exercise of all equity instruments was anti-dilutive and, therefore, not included in the net diluted loss per share calculations for those periods.

No cash dividends were declared or paid during the three months ended March 31, 2026 and 2025.